Devum Life Sciences Private Limited
About Devum Life Sciences Private Limited
Data last updated:
Devum Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2020PTC362398. Its GSTIN is 07AATCA3554H1ZE (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Ahead Education Solutions Private Limited. It is led by directors Sumant Krishna Srivastava and Priyanka Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 208 2nd Floor Kh. No – 311/26 Village Chattarpur Near Yes Bank, New Delhi, Delhi, India – 110074.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Devum Life Sciences has one previous CIN (Corporate Identification Number): U80903DL2020PTC362398. The current CIN is U85100DL2020PTC362398, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100DL2020PTC362398 | Current |
| U80903DL2020PTC362398 | Previous |
Contact details
Devum Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address208 2nd Floor Kh. No – 311/26 Village Chattarpur Near Yes Bank, New Delhi, Delhi, India – 110074
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Devum Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Devum Life Sciences Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Devum Life Sciences Private Limited, buy the company report.
Board of directors of Devum Life Sciences Private Limited
Devum Life Sciences has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumant Krishna Srivastava | Director | 07 Jun 2021 | 5 Years 5 Months | Current |
| Priyanka Srivastava | Director | 16 Jun 2023 | 3 Years 4 Months | Current |
Auditor
Devum Life Sciences Private Limited is audited by PRITAM KUMAR for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRITAM KUMAR | FY 2023 | 036503N |
Shareholding
The shareholding of Devum Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Devum Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Devum Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Devum Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Devum Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AATCA3554H1ZE | Delhi | Active | 09 Feb 2021 |
To see the full GST registrations and return filing status of Devum Life Sciences Private Limited, buy the company report.
Recent activity
Devum Life Sciences Private Limited has 7 board changes on record since 2021: 2 appointments and 5 cessations. The latest: Kuljit Singh Popli ceased to be Director on 30 Dec 2023.
Frequently asked questions
Devum Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 February 2020 (6+ years old) and is registered under CIN U85100DL2020PTC362398.
Devum Life Sciences has 2 current directors:
- Sumant Krishna Srivastava - Director
- Priyanka Srivastava - Director
The latest financial statements of Devum Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Devum Life Sciences is 07AATCA3554H1ZE, registered in Delhi.
The CIN (Corporate Identification Number) of Devum Life Sciences is U85100DL2020PTC362398. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Devum Life Sciences was incorporated on 27 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
Kuljit Singh Popli ceased to be Director on 30 Dec 2023. Sumant Krishna Srivastava ceased to be Additional Director on 30 Dec 2023. Priyanka Srivastava was appointed as Director on 16 Jun 2023. Devum Life Sciences has 7 board changes on record in total.
The registered office of Devum Life Sciences is at 208 2nd Floor Kh. No – 31126 Village Chattarpur Near Yes Bank, New Delhi, Delhi, India – 110074.
Devum Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Devum Life Sciences is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
